Applied Fundamental Research LLC Has $10.96 Million Stock Position in UFP Technologies, Inc. (NASDAQ:UFPT)

Applied Fundamental Research LLC decreased its position in UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) by 8.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 44,841 shares of the industrial products company's stock after selling 4,133 shares during the quarter. UFP Technologies makes up 8.6% of Applied Fundamental Research LLC's investment portfolio, making the stock its 6th largest position. Applied Fundamental Research LLC owned 0.58% of UFP Technologies worth $10,964,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. First National Advisers LLC purchased a new position in shares of UFP Technologies during the 4th quarter worth approximately $571,000. Envestnet Portfolio Solutions Inc. bought a new stake in shares of UFP Technologies during the fourth quarter valued at approximately $201,000. Swiss National Bank grew its stake in UFP Technologies by 6.3% in the fourth quarter. Swiss National Bank now owns 15,100 shares of the industrial products company's stock worth $3,692,000 after purchasing an additional 900 shares during the period. Avantax Advisory Services Inc. raised its holdings in UFP Technologies by 11.2% in the fourth quarter. Avantax Advisory Services Inc. now owns 862 shares of the industrial products company's stock worth $211,000 after purchasing an additional 87 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in UFP Technologies by 24.7% during the fourth quarter. EverSource Wealth Advisors LLC now owns 333 shares of the industrial products company's stock valued at $81,000 after buying an additional 66 shares during the period. 87.28% of the stock is owned by institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of UFP Technologies from a "hold" rating to a "sell" rating in a research report on Thursday, January 23rd.

Insiders Place Their Bets

In other news, Director Daniel C. Croteau sold 6,846 shares of the stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $228.41, for a total transaction of $1,563,694.86. Following the sale, the director now owns 1,785 shares in the company, valued at $407,711.85. This represents a 79.32 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 6.17% of the company's stock.

UFP Technologies Stock Down 1.0 %

Shares of UFP Technologies stock traded down $2.07 during midday trading on Thursday, hitting $212.62. The company had a trading volume of 75,819 shares, compared to its average volume of 74,806. The company has a 50 day moving average of $248.54 and a 200 day moving average of $279.41. The stock has a market capitalization of $1.63 billion, a P/E ratio of 30.33 and a beta of 1.15. UFP Technologies, Inc. has a 52-week low of $200.15 and a 52-week high of $366.41. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.43 and a current ratio of 2.57.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last issued its quarterly earnings results on Tuesday, February 25th. The industrial products company reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.45. The firm had revenue of $144.07 million during the quarter, compared to the consensus estimate of $141.67 million. UFP Technologies had a return on equity of 18.92% and a net margin of 11.74%.

About UFP Technologies

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.